Cubist Systematic Strategies, LLC Immunovant, Inc. Transaction History

Cubist Systematic Strategies, LLC

$15.8 Billion
Q3 2024

A detailed history of Cubist Systematic Strategies, LLC transactions in Immunovant, Inc. stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 10,800 shares of IMVT stock, worth $297,108. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,800

Previous 10,800 -0.0%

Holding current value

$297,108

Previous $285,000 4.21%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$18.55 - $39.96 $1.94 Million - $4.19 Million	104,799 Added 132.01%	184,187 $7.07 Million
Q2 2023 Aug 14, 2023	SELL	$14.2 - $23.75 $1.06 Million - $1.77 Million	-74,431 Reduced 48.39%	79,388 $1.51 Million
Q1 2023 May 15, 2023	BUY	$15.27 - $19.72 $1.04 Million - $1.35 Million	68,381 Added 80.04%	153,819 $2.39 Million
Q4 2022 Feb 14, 2023	BUY	$6.59 - $17.75 $336,136 - $905,374	51,007 Added 148.14%	85,438 $1.52 Million
Q3 2022 Nov 14, 2022	BUY	$3.93 - $6.37 $24,617 - $39,901	6,264 Added 22.24%	34,431 $192,000
Q2 2022 Aug 15, 2022	SELL	$3.38 - $5.65 $39,765 - $66,472	-11,765 Reduced 29.46%	28,167 $110,000
Q1 2022 May 16, 2022	SELL	$5.06 - $8.77 $141,740 - $245,665	-28,012 Reduced 41.23%	39,932 $220,000
Q4 2021 Feb 14, 2022	SELL	$7.33 - $9.32 $407,973 - $518,732	-55,658 Reduced 45.03%	67,944 $579,000
Q3 2021 Nov 15, 2021	BUY	$7.01 - $11.37 $502,399 - $814,876	71,669 Added 138.0%	123,602 $1.07 Million
Q2 2021 Aug 16, 2021	SELL	$9.4 - $16.85 $759,595 - $1.36 Million	-80,808 Reduced 60.88%	51,933 $549,000
Q1 2021 May 17, 2021	BUY	$13.08 - $49.6 $1.6 Million - $6.05 Million	121,968 Added 1132.16%	132,741 $2.13 Million
Q4 2020 Feb 16, 2021	SELL	$36.36 - $52.71 $507,440 - $735,620	-13,956 Reduced 56.44%	10,773 $498,000
Q3 2020 Nov 16, 2020	BUY	$22.61 - $38.9 $457,626 - $787,336	20,240 Added 450.88%	24,729 $870,000
Q2 2020 Aug 14, 2020	BUY	$13.87 - $28.44 $57,560 - $118,026	4,150 Added 1224.19%	4,489 $109,000
Q1 2020 May 15, 2020	BUY	$8.36 - $17.13 $2,834 - $5,807	339 New	339 $5,000

Others Institutions Holding IMVT

# of Institutions

211

Shares Held

66.9M

Call Options Held

2.3M

Put Options Held

631K

View Full List

About Immunovant, Inc.

Ticker IMVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 129,077,000
Market Cap $3.55B
Description
Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of mya...

More about IMVT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account

Cubist Systematic Strategies, LLC Immunovant, Inc. Transaction History